Horizon Therapeutics Public Limited Company Announces New Analysis of Adhering to Uninterrupted Full Course of Treatment with Tepezza to Support Thyroid Eye Disease Patient Outcomes

Horizon Therapeutics Public Limited Company announced new data showing that disrupting the recommended TEPEZZA treatment regimen by lengthening the amount of time between infusions can increase the...

Related Keywords

Washington ,District Of Columbia ,United States ,American , ,Meeting Of The American Thyroid Association ,Horizon Therapeutics Public Limited Company ,Drug Administration ,Clinical Activity Score ,Annual Meeting ,American Thyroid Association ,Ophthalmopathy Quality ,Infusion Reactions ,Inflammatory Bowel Disease ,Impairment Including Hearing Loss ,Markets ,